
Let us guide you on the Path to Patients
Our Services
Preclinical & Regulatory Strategy
Design and deliver a preclinical activity roadmap
Exploratory and investigative toxicology strategies
Nonclinical study alignment with regulatory strategies
Nonclinical strategies to support clinical development plans and the proposed indication
IND-enabling toxicology study strategies and interpretation of results, including e.g., pathology, PK/PD, together with long-term and specialty toxicology evaluations
Business Development Strategy
Supply Chain
R&D Strategy
Market Access
Market Research
Sales and Operations
Opportunity Mapping
Business Analysis/Forecasting
Commercial Strategy/Marketing
Business Plans/Investor Pitch Decks
End-to-end Business Development expertise
Tailored development strategies to align with corporate goals
Technical expertise to support due diligence (buy side or sell side)
Functional capabilities to build valuations to inform management decisions and negotiation strategies
Alliance management to support ongoing obligations from signed partnerships
Negotiation strategies and deal execution for any type of corporate transaction (license/collaboration/M&A/etc.)
Commercialization & IP Strategy
Strategic IP support
IP/technology licensing
Business plan development
Spin-out company creation
Techno-commercial project appraisal
IP/project portfolio evaluation and triage
Economic Impact studies and project valuation
Review of effectiveness of translational research fund schemes
Organizational improvement of technology transfer and incubation services
Global Networking
Identification of potential partners
Management of the due diligence process
Preparation and maintenance of data rooms
Preparation of program materials to share with external parties
Project & Portfolio Management
Project Management
Innovation management
Study outsourcing and monitoring
Preclinical development plans and budgets
Project evaluations and due diligence support
Technical Writing & Assessments
Environmental Risk Assessments
Toxicological Risk Assessments for Impurities, Leachables & Extractables
Nonclinical overviews and preclinical parts of IB, IMPD, IND, etc.
Determination of Permitted Daily Exposure & Occupational Exposure Limits
Biocompatibility Assessments for Medical Devices (acc. to DIN EN ISO 10993)
Study Support
Pharmacokinetic and metabolism profiling
Nonclinical pharmacology and translational assessments
PK/PD modeling support and evaluate predictive models
Analysis and intpretation of resulting data at agreed milestones
Coordinate and oversee the outsourcing of laboratory nonclinical studies
PK/PD evaluation, preliminary human dose/exposure projections and safety margins
Consulting On-Demand
This approach is often appealing to customers who wish to leverage the resources and expertise of our consulting group for more short-term initiatives. A consultation engagement could include:
Guidance on regulatory requirements
Literature research and competitive analysis
De novo assay development, review, and execution
3rd party vendor assessment, recommendations, and data review for CDMOs and CROs
Data analyses, interpretation, and high-quality advanced study reports
"Path2P was instrumental in guiding our preclinical and regulatory strategy. Their team delivered clear, actionable insights and felt like a true extension of our startup. Thanks to their support, we’re advancing with confidence toward our IND submission."
— CEO, BIOPHARMA STARTUP